SCHEMBL3209467

SCHEMBL3209467

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1280244 1.00 LMNA (0.35) LMNA
SCHEMBL9556712 1.00 LMNA (0.35) LMNA
SCHEMBL247546 0.97 LMNA (0.30) LMNA
SCHEMBL7052168 0.97 LMNA (0.30) LMNA
SCHEMBL7051335 0.88
Perfluoro Tert-Butylcyclohexane SCHEMBL896281 0.87
SCHEMBL20475017 0.85
SCHEMBL5159854 0.82 MEN1 (0.38)
Perflenapent SCHEMBL8841157 0.82 LMNA (0.47) LMNA
SCHEMBL5025386 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2198869-B1 TREHALOSE FOR THE TREATMENT OR PREVENTION OF VASOSPASM NEXT 21 K K (JP) 2015-09-16 EP disclosed
US-8283337-B2 Therapeutic or prophylactic agent for vasoconstriction NEXT21 K.K. (JP) 2012-10-09 US disclosed
EP-2198869-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION Next 21 K.K. (JP) 2010-06-23 EP disclosed
US-20100035837-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION NEXT21 K.K. (JP) 2010-02-11 US disclosed